NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome

作者: Joerg G. D. Birkmayer

DOI:

关键词:

摘要: A method for treating Chronic Fatigue Syndrome or alleviating symptoms thereof wherein the reduced form of nicotinamide adenine dinucleotide (NADH) phosphate (NADPH) physiologically compatible salts derivatives NADH and/or NADPH are administered to a person suffering from syndrome its symptoms. Patients so treated exhibit greatly improved physical strength and performance over time, their including fatigue, muscle pain weakness, headaches alleviated.

参考文章(15)
Walter Prof. Dr. Birkmayer, NADH and NADPH as energy-substitutes ,(1992)
Peter-Andreas Loschmann, Helmut Wachtel, Reinhard Horowski, Walter Birkmayer, Walther Birkmayer, Jorg Birkmayer, Agent for treatment of parkinson's disease ,(1989)
Ernir Snorrason, Treatment of fatigue syndrome ,(1992)
Atsushi Uchida, Method for treatment of chronic fatigue syndrome Official Gazette of the United States Patent and Trademark Office Patents. ,vol. 1175, pp. 1141- ,(1993)